Latest Stock Split Details
Key information about Ligand Pharmaceuticals Incorporated's most recent stock split
Split Date: 2022-11-02
Split Ratio: 1603:1000
Price Before Split: $109.00
Price After Split: $68.00
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.60 times more shares (a 1603:1000 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Ligand Pharmaceuticals Incorporated's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2022-11-02 | 1603:1000 | No | $109.00 | $68.00 |
| 2010-11-19 | 1:6 | Yes | $0.59 | $0.10 |
About Ligand Pharmaceuticals Incorporated
Company overview and industry information
Ligand Pharmaceuticals Incorporated (LGND) operates in the Biotechnology industry. The recent 1603-for-1000 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Biotechnology
Go to Ligand Pharmaceuticals Incorporated Summary